Pharmaceutical grade will lead benzethonium chloride sales through 2036 with 61.4% of the grade segment in 2026. The market was valued at USD 35.5 million in 2025 and is projected to reach USD 85.3 million by 2036, creating an incremental opportunity of USD 49.8 million between 2026 and 2036.